$20.50
-0.44%Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Steady FCF growth indicates consistent cash generation improvement. On a positive trajectory.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
OSCR โข NYSE
| Oscar Health, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||
-442.9M | 26.1M | -270.6M | -609.6M | -571.4M | -406.8M | -261.2M | |
28.9M | 32.1M | 30.7M | 15.3M | 14.6M | 11.3M | 6.9M | |
2.4M | -2.3M | 58K | -165K | -101K | -67K | -426K | |
87.7M | 109.8M | 159.7M | 112.3M | 86.3M | 35.9M | 33.6M | |
-40.2M | -26.4M | 86K | 7.5M | 41.2M | 6.8M | -6.4M | |
(17.5M) | (674K) | (2.4M) | (1.9M) | (697K) | (1.5M) | (1.8M) | |
1.5B | 838.9M | -192.1M | 855M | 247.7M | 575.7M | 62.2M | |
1.1B | 978.2M | -272.2M | 380.3M | -181.7M | 222.7M | -165.4M | |
INVESTING ACTIVITIES | |||||||
-36.4M | -27.9M | -25.6M | -29M | -25.9M | -14M | -26M | |
(0.0) | (0.0) | (0.0) | (0.0) | (7.2M) | (0.0) | (0.0) | |
-1B | -2.1B | -837M | -1.2B | -1.8B | -1B | -877.7M | |
805M | 770M | 1.4B | 994.1M | 1.1B | 671.6M | 1.1B | |
4.3M | 3.9M | -2.3M | 1.1M | -555K | -1.2M | -7.1M | |
-241.1M | -1.4B | (577.2M) | -226.5M | -774.5M | -344.7M | (150.5M) | |
FINANCING ACTIVITIES | |||||||
55M | 68.4M | 4M | 1.3M | 1.3B | 0.0 | -3M | |
348.2M | 0.0 | 0.0 | 305M | -153.2M | 147M | 0.0 | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -3M | |
-4M | 0.0 | 2.5M | -5.2M | 43.6M | 89M | 873K | |
399.2M | 68.4M | 6.4M | 301.1M | 1.2B | 611.7M | -2.1M | |
CASH FLOW SUMMARY | |||||||
1.3B | -340.9M | 311.5M | 454.9M | 282.5M | 489.7M | -17M | |
1.6B | 1.9B | 1.6B | 1.1B | 843.1M | 353.4M | 370.4M | |
2.8B | 1.6B | 1.9B | 1.6B | 1.1B | 843.1M | 353.4M | |
1.1B | 950.3M | -297.7M | 351.3M | -207.6M | 208.7M | -191.4M |
OSCR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 02, 2026 | May 29, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 04, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 21, 2026 | April 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 13, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 06, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 29, 2025 | December 22, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 03, 2025 | 2025 |
Continue your OSCR research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.